<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>COVID-19 and Glaucoma Management - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjVf5RsqgdU7yRLQhuZQAAAAA","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"COVID-19_and_Glaucoma_Management","wgTitle":"COVID-19 and Glaucoma Management","wgCurRevisionId":87670,"wgRevisionId":87670,"wgArticleId":17570,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"COVID-19_and_Glaucoma_Management","wgRelevantArticleId":17570,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove"
:[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="This article describes logistical challenges and solutions to provision of glaucoma care in the era of the COVID-19 pandemic."/>
<meta name="date" content="2022-12-24"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="COVID-19 and Glaucoma Management" href="/w/index.php?title=Special:ExportRDF/COVID-19_and_Glaucoma_Management&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-COVID-19_and_Glaucoma_Management rootpage-COVID-19_and_Glaucoma_Management layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=COVID-19+and+Glaucoma+Management" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=COVID-19+and+Glaucoma+Management" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzysnej1"></button>
					<div class="collapse navbar-collapse hbpzysnej1" id="hbpzysnej1">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/COVID-19_and_Glaucoma_Management" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:COVID-19_and_Glaucoma_Management&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="COVID-19_and_Glaucoma_Management#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">COVID-19 and Glaucoma Management</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#8201;<a href="/User:Gelilah.Yohannes" title="User:Gelilah.Yohannes">Gelilah Yohannes, MS</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Gelilah.Yohannes" title="User:Gelilah.Yohannes">Gelilah Yohannes, MS</a>,&#160;<a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a> on December 25, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Introduction"><span class="tocnumber">1</span> <span class="toctext"><b>Introduction</b></span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Clinical_Examination"><span class="tocnumber">2</span> <span class="toctext"><b>Clinical Examination</b></span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#IOP_Measurement"><span class="tocnumber">2.1</span> <span class="toctext"><b>IOP Measurement</b></span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Visual_Field_Examination"><span class="tocnumber">2.2</span> <span class="toctext"><b>Visual Field Examination</b></span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Teleglaucoma"><span class="tocnumber">3</span> <span class="toctext"><b>Teleglaucoma</b></span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Advantages"><span class="tocnumber">3.1</span> <span class="toctext"><b>Advantages</b></span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Drawbacks"><span class="tocnumber">3.2</span> <span class="toctext"><b>Drawbacks</b></span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-8"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext"><b>Treatment</b></span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Medication_Adherence"><span class="tocnumber">4.1</span> <span class="toctext"><b>Medication Adherence</b></span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Surgical_Practice"><span class="tocnumber">4.2</span> <span class="toctext"><b>Surgical Practice</b></span></a>
<ul>
<li class="toclevel-3 tocsection-11"><a href="#Trabeculectomy"><span class="tocnumber">4.2.1</span> <span class="toctext"><b>Trabeculectomy</b></span></a></li>
</ul>
</li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Future_Directions"><span class="tocnumber">5</span> <span class="toctext"><b>Future Directions</b></span></a></li>
</ul>
</div>

<h2><span class="mw-headline" id="Introduction"><b>Introduction</b></span></h2>
<p>Glaucoma is the leading global cause of preventable and irreversible blindness. The current COVID-19 pandemic has drastically altered the landscape in which glaucoma care must be delivered. Cancelations of clinic visits, deemed non-urgent, were compounded by social distancing measures and potential fear of COVID-19 infection.<sup id="cite_ref-1" class="reference"><a href="#cite_note-1">&#91;1&#93;</a></sup> The number of newly diagnosed patients and patients on regular follow-up declined as well as the number of trabeculectomies.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup> To replace sudden and unexpected cancelation of in-person visits, virtual clinics were opened with their own advantages and drawbacks. Here we present the evolving challenges of glaucoma management during the COVID-19 and lessons for the future.
</p>
<h2><span class="mw-headline" id="Clinical_Examination"><b>Clinical Examination</b></span></h2>
<h3><span class="mw-headline" id="IOP_Measurement"><b>IOP Measurement</b></span></h3>
<p>Recent advances in home monitoring of intraocular pressure (IOP) and visual fields have potential to expand teleglaucoma.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">&#91;3&#93;</a></sup> Rebound tonometer (Icare HOME) is an approved device, but not widely adopted due to issues with cost of the device and patient-self monitoring. Recently approved for use in Europe, the Eyemate telemetric IOP sensor acts as a permanent implantable monitoring device for use in patients with open-angle glaucoma.
</p>
<h3><span class="mw-headline" id="Visual_Field_Examination"><b>Visual Field Examination</b></span></h3>
<p>Mask-related artifacts in VF examination seem to be more common, potentially mistaken for glaucoma progression damage.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup> Types of visual field artifacts that may be mask-related include inferior visual defects, higher fixation losses, and false-positive errors.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">&#91;5&#93;</a></sup> Fogging of eyeglasses before standard automated perimetry is a strong predictor of low reliability. Taping the upper edges of face masks is a suggested alternative technique. However, while fogging can induce artifacts and reduce test reliability, it may also conceal true VF defects.<sup id="cite_ref-6" class="reference"><a href="#cite_note-6">&#91;6&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Teleglaucoma"><b>Teleglaucoma</b></span></h2>
<h3><span class="mw-headline" id="Advantages"><b>Advantages</b></span></h3>
<p>Glaucoma requires regular follow-up to avoid its potentially blinding effect. Teleglaucoma is a growing field increasing patient access and decreasing the need for long-distance travel for patients in adherence with social distancing concerns during the pandemic.<sup id="cite_ref-:0_7-0" class="reference"><a href="#cite_note-:0-7">&#91;7&#93;</a></sup>
</p><p>Teleglaucoma programs can be used for long-term treatment monitoring and diagnostic consultations. Key components include patient history, equipment, fundus photography, retinal nerve fiber layer imaging, IOP measurement, pachymetry, anterior chamber imaging, gonioscopy, and imaging software. Various models exist including screening, diagnostic consultation, and home monitoring. In addition, drive-through IOP clinics have been shown to be a safe way to monitor glaucoma patients during COVID-19.<sup id="cite_ref-:1_8-0" class="reference"><a href="#cite_note-:1-8">&#91;8&#93;</a></sup> “Digitally Integrated Visits” have been characterized, separating glaucoma testing performed by technical personnel from interactions with ophthalmologists at the same time.<sup id="cite_ref-:0_7-1" class="reference"><a href="#cite_note-:0-7">&#91;7&#93;</a></sup> &#160;
</p><p><br />
Because glaucoma management requires frequent monitoring of glaucoma progression in existing patients, teleglaucoma may be beneficial to assess in treatment compliance, to increase efficiency of follow up, and to monitor clinical parameters such as IOP.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup> &#160;Cases have been reported during the pandemic of permanent and severe vision loss as a consequence of delayed follow-up due to insufficient capacity within hospital eye services.<sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup> Teleglaucoma, therefore, can improve access to eyecare for those in underserved or remote areas. Its rapid nature allows patients to be seen quickly and conveniently, giving patients more control over their time.
</p>
<h3><span class="mw-headline" id="Drawbacks"><b>Drawbacks</b></span></h3>
<p>Glaucoma is diagnosed according to consensus findings from IOP measurements, fundus photographs, VF exams and OCT. There are clear limitations to certain modalities of teleglaucoma, for example, consults over the phone. IOP measurements cannot be checked remotely. Thus, teleglaucoma may be more suited towards the monitoring of patients with an established diagnosis, rather than new patients. Ultimately, not all patients are well-suited candidates for teleglaucoma may be better seen in person.
</p><p><br />
Teleglaucoma can provide healthcare access to patients in less resourced areas, however, there may be a tradeoff for the most vulnerable patients who may have barriers accessing the internet and certain digital platforms for patient-physician communication.<sup id="cite_ref-11" class="reference"><a href="#cite_note-11">&#91;11&#93;</a></sup><sup id="cite_ref-:2_12-0" class="reference"><a href="#cite_note-:2-12">&#91;12&#93;</a></sup> Cultural attitudes and languages may also pose additional challenges.&#160; Furthermore, there is no valid VF or IOP measurement method through telemedicine that meets HIPAA guidelines.&#160; Overall, the consensus from current literature does not recommend remote assessment alone to monitor glaucoma.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup>
</p><p><br />
</p>
<h2><span class="mw-headline" id="Treatment"><b>Treatment</b></span></h2>
<h3><span class="mw-headline" id="Medication_Adherence"><b>Medication Adherence</b></span></h3>
<p>Poor compliance and adherence to medications are well-known drawbacks for glaucoma patients. Evidence suggests that the pandemic has worsened adherence to ocular hypotensive medications which appears to be related to patient resilience, notably lower in patients of older age, greater number of eye diseases, and lower education level.<sup id="cite_ref-:3_14-0" class="reference"><a href="#cite_note-:3-14">&#91;14&#93;</a></sup>  Medication adherence may be improved with teleglaucoma to maintain the physician-patient relationship and motivation.
</p>
<h3><span class="mw-headline" id="Surgical_Practice"><b>Surgical Practice</b></span></h3>
<h4><span class="mw-headline" id="Trabeculectomy"><b>Trabeculectomy</b></span></h4>
<p>The frequency of trabeculectomies has decreased during the COVID-19 pandemic in part due to the number of postoperative visits and procedures required. Conventional and micropulse diode laser, glaucoma drainage devices, deep sclerectomy and Preserflo appear to be alternatives as the postoperative care for these procedures is typically less intensive.<sup id="cite_ref-:2_12-1" class="reference"><a href="#cite_note-:2-12">&#91;12&#93;</a></sup> <sup id="cite_ref-:4_15-0" class="reference"><a href="#cite_note-:4-15">&#91;15&#93;</a></sup>&#160;In the UK, a shift towards transscleral diode lasers has been noted. <sup id="cite_ref-:3_14-1" class="reference"><a href="#cite_note-:3-14">&#91;14&#93;</a></sup> One study demonstrated potential efficacy for micropulse transscleral cyclophotocoagulation (MP-TSCPC) as a primary procedure for POAG during the pandemic.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">&#91;16&#93;</a></sup>
</p><p><br />
Desires to minimize patient contact during surgery and simplify postoperative care in order to reduce the risk of COVID-19 transmission have had a large impact on the type of surgery offered after the outbreak with a tendency for less post-operative follow up, interventions, and shorter surgical time.<sup id="cite_ref-:4_15-1" class="reference"><a href="#cite_note-:4-15">&#91;15&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Future_Directions"><b>Future Directions</b></span></h2>
<p>The COVID-19 pandemic has created a new landscape in which ophthalmic care and glaucoma care will be delivered in the future. Telemedicine, including phone consultations and virtual clinics rose to prominence as means of providing effective ophthalmic care.&#160; However, telemedicine has clear drawbacks in glaucoma where measurements obtained at in-person patient visits play a pivotal role in treatment decision-making. <sup id="cite_ref-:1_8-1" class="reference"><a href="#cite_note-:1-8">&#91;8&#93;</a></sup>
</p><p><br />
Many patients have had their access to healthcare curtailed and follow-ups canceled due to the heavy burden that the pandemic has placed on healthcare systems globally. In the case of follow-up appointments, certain populations are disproportionally impacted. Furthermore, the COVID-19 pandemic has disproportionally impacted patients of older age and Black and brown communities, particularly vulnerable to glaucomatous disease. More planning is required to ensure medication and treatment adherence and address the challenges in managing glaucoma care during subsequent waves of the pandemic.
</p>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-1"><span class="mw-cite-backlink"><a href="#cite_ref-1">↑</a></span> <span class="reference-text">Liebmann JM. Ophthalmology and Glaucoma Practice in the COVID-19 Era. <i>J Glaucoma</i>. Jun 2020;29(6):407-408. doi:10.1097/IJG.0000000000001519</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><a href="#cite_ref-2">↑</a></span> <span class="reference-text">Awwad MA, Masoud M. Influence of COVID19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region. <i>Clin Ophthalmol</i>. 2021;15:4565-4572. doi:10.2147/OPTH.S342682</span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><a href="#cite_ref-3">↑</a></span> <span class="reference-text">Mansouri K, Kersten-Gomez I, Hoffmann EM, Szurman P, Choritz L, Weinreb RN. Intraocular Pressure Telemetry for Managing Glaucoma during the COVID-19 Pandemic. <i>Ophthalmol Glaucoma</i>. Sep-Oct 2021;4(5):447-453. doi:10.1016/j.ogla.2020.12.008</span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><a href="#cite_ref-4">↑</a></span> <span class="reference-text">Gomez Mariscal M, Munoz-Negrete FJ, Munoz-Ramon PV, Aguado Casanova V, Jaumandreu L, Rebolleda G. Avoiding mask-related artefacts in visual field tests during the COVID-19 pandemic. <i>Br J Ophthalmol</i>. Feb 17 2021;doi:10.1136/bjophthalmol-2020-318408</span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><a href="#cite_ref-5">↑</a></span> <span class="reference-text">Bayram N, Gundogan M, Ozsaygili C, Vural E, Cicek A. The Impacts of Face Mask Use on Standard Automated Perimetry Results in Glaucoma Patients. <i>J Glaucoma</i>. Apr 1 2021;30(4):287-292. doi:10.1097/IJG.0000000000001786</span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><a href="#cite_ref-6">↑</a></span> <span class="reference-text">El-Nimri NW, Moghimi S, Fingeret M, Weinreb RN. Visual Field Artifacts in Glaucoma With Face Mask Use During the COVID-19 Pandemic. <i>J Glaucoma</i>. Dec 2020;29(12):1184-1188. doi:10.1097/IJG.0000000000001706</span>
</li>
<li id="cite_note-:0-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_7-0">7.0</a></sup> <sup><a href="#cite_ref-:0_7-1">7.1</a></sup></span> <span class="reference-text">Gan K, Liu Y, Stagg B, Rathi S, Pasquale LR, Damji K. Telemedicine for Glaucoma: Guidelines and Recommendations. <i>Telemed J E Health</i>. Apr 2020;26(4):551-555. doi:10.1089/tmj.2020.0009</span>
</li>
<li id="cite_note-:1-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_8-0">8.0</a></sup> <sup><a href="#cite_ref-:1_8-1">8.1</a></sup></span> <span class="reference-text">Powell S, Doolan E, Curtin K, Doyle A, O'Brien C. Audit of outcomes following attendance at the City West drive-through IOP glaucoma clinic during the COVID-19 pandemic. <i>Ir J Med Sci</i>. Jan 16 2022;doi:10.1007/s11845-021-02893-9</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><a href="#cite_ref-9">↑</a></span> <span class="reference-text">Lam PY, Chow SC, Lai JSM, Choy BNK. A review on the use of telemedicine in glaucoma and possible roles in COVID-19 outbreak. <i>Surv Ophthalmol</i>. Nov-Dec 2021;66(6):999-1008. doi:10.1016/j.survophthal.2021.03.008</span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><a href="#cite_ref-10">↑</a></span> <span class="reference-text">Jayaram H, Strouthidis NG, Gazzard G. The COVID-19 pandemic will redefine the future delivery of glaucoma care. <i>Eye (Lond)</i>. Jul 2020;34(7):1203-1205. doi:10.1038/s41433-020-0958-1</span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><a href="#cite_ref-11">↑</a></span> <span class="reference-text">Li JO, Liu H, Ting DSJ, et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: A global perspective. <i>Prog Retin Eye Res</i>. May 2021;82:100900. doi:10.1016/j.preteyeres.2020.100900</span>
</li>
<li id="cite_note-:2-12"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_12-0">12.0</a></sup> <sup><a href="#cite_ref-:2_12-1">12.1</a></sup></span> <span class="reference-text">Parrish RK, 2nd, Higginbotham EJ. What Does Telemedicine Mean for the Care of Patients With Glaucoma in the Age of COVID-19? <i>Am J Ophthalmol</i>. Oct 2020;218:A1-A2. doi:10.1016/j.ajo.2020.07.038</span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><a href="#cite_ref-13">↑</a></span> <span class="reference-text">Odden JL, Khanna CL, Choo CM, et al. Telemedicine in long-term care of glaucoma patients. <i>J Telemed Telecare</i>. Jan-Feb 2020;26(1-2):92-99. doi:10.1177/1357633X18797175</span>
</li>
<li id="cite_note-:3-14"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:3_14-0">14.0</a></sup> <sup><a href="#cite_ref-:3_14-1">14.1</a></sup></span> <span class="reference-text">Racette L, Abu SL, Poleon S, Thomas T, Sabbagh N, Girkin CA. The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma. <i>Ophthalmology</i>. Oct 19 2021;doi:10.1016/j.ophtha.2021.10.009</span>
</li>
<li id="cite_note-:4-15"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:4_15-0">15.0</a></sup> <sup><a href="#cite_ref-:4_15-1">15.1</a></sup></span> <span class="reference-text">Holland LJ, Kirwan JF, Mercieca KJ. Effect of COVID-19 pandemic on glaucoma surgical practices in the UK. <i>Br J Ophthalmol</i>. Apr 30 2021;doi:10.1136/bjophthalmol-2021-319062</span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><a href="#cite_ref-16">↑</a></span> <span class="reference-text">Chang HL, Chao SC, Lee MT, Lin HY. Micropulse Transscleral Cyclophotocoagulation as Primary Surgical Treatment for Primary Open Angle Glaucoma in Taiwan during the COVID-19 Pandemic. <i>Healthcare (Basel)</i>. Nov 17 2021;9(11)doi:10.3390/healthcare9111563</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035150
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0 seconds
CPU time usage: 0.125 seconds
Real time usage: 0.455 seconds
Preprocessor visited node count: 558/1000000
Post‐expand include size: 4747/2097152 bytes
Template argument size: 1401/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 1853/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  226.692      1 Template:Article
100.00%  226.692      1 -total
 66.60%  150.974      4 Template:Infobox_section
 16.96%   38.452      4 Template:UserLookup
  2.38%    5.395      1 Template:Get_active_contest
  2.02%    4.578      1 Template:Review_expired
  0.96%    2.167      1 Template:Infobox_begin
  0.41%    0.923      1 Template:Infobox_end
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;oldid=87670">https://eyewiki.org/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;oldid=87670</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzysng8u">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/COVID-19_and_Glaucoma_Management" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/COVID-19_and_Glaucoma_Management" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;oldid=87670" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=COVID-19_and_Glaucoma_Management&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on December 25, 2022, at 16:22.</div>
					<div>This page has been accessed 5,661 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAFgAAAAfCAMAAABUFvrSAAACJVBMVEXe3t62trbLy8vGxsbAwMDX19e6urqsrKxHcEzQ0NC2tratra2oqKixsbHd3eDFxcXe3t7U1NTa2trX19fQ0NDV1dWNjY2dnZ2UlJSUlJTS0tKUlJSWlpbR0dGenp79/f38/Pz+/v7t7e3v7+/u7u7s7Oz19fX29vb6+vr7+/vz8/Pz8/P4+fnw8PD39/gWTq/09PX6+vktX7b/sg8XT7F6mc/f5OwhVrNvkMthhsfT2+j7rQ/M1eZqjcmFotPs7e9Cb722xuFResK/zOObstnu7/Grvd3M1+mNqNY6aLoaUbEaUbZWfsTk6fE2Zrnp7O8bTq0kWLQuYcpcg8Xh5/Byk83a4eukud1/nM+6yeQkWcGwwuDxnRQyYrigttvI0+gpW7XGyttLdsBni8geVLo0Z9XlkCPb4u+QqtcfVLLo7PNHcr73phFGX6HsmBnpkxg6bNwnXcbX3er19vnr7/SVrdhuhLl+j70vVqY6Xqv0oxJVcbQhV76DjKTz9ffQ2evE0OZAbbzu7/PS1uFufrDnrGgpSZjy8/SQnMFddrKuekXSiCsgTKRaaZHejy9yang3VptNaqspWbnmliy3j2/m6OzT3e7x8fL4+v3p6uwaN2re0cifqLiLiZWYhYGYb0xXYn+5g0xwiMKYpc2BcHZmW2srRXpGWIhecKfilz4+WID2+PyosMywqbGqss1aVnLZq33p1sGklZqrp7dkfr7CpY9yg59Ud6QZAAAAH3RSTlPfBN/f39/f2wDf39vV3/7N2rrEz5D5c8ONuHaPuXXDImoxqwAABO1JREFUSMe1kQdz01gQgBXaBS4w9OtHwMFSdPKTUNxkW+61xN2Je4tLHJNOGukkAUINJTzaUIbO9fr7TpLtS44DZiC5b6Sn3dW+TysJaWz4cv9eZFPZu/+bhkakYR88WqP59u3vjxzdDCT7GpCD4qNH3sEGzOhB5MCR/4PmA8j25uZ33t0A23lxff5hZTIzOrz2Ph8qK936l7i1tT7hk8DAoHNsbeLWKjPdQcZ+qvX9tHMNXca1XBDXHtL6x2Bh0HWtuXUo8oTgC1gVpcdsdpew92PUYtjwzFq+E9mJYfXxx1x5l2/l5Vhy0DW6TuyQCZcR2hnswXJM0h+203471u5WKMIE5mDpspIIO8sZTMZiIbczY6+JCaI+/sJZ38qjP28+nQjkx/mcqGJ26rW3iKg/fYphCL1jNk5WbqXI0nBnu00RJ2j9bNRp6MmFS0SYIXLuUlQ5w22qizHr5MTyy2u/3XxVvHHlwtWVa/xTCQIIlEaMzrgswzA5P9BrAciYASqNoiNdjL8b0GYAHN3AGAEgzPSQc9UtYCeyBQAMO2G9PhhzXfp9qdifSCT6Lj788QQnrvWEuNPI2um0LW0D+m4A6E4AnIZOeq7ksQuJvi6eUXRW+8EWXsxNPhkYGJiSXr7Rd1qtVp9MXHkgIurzAkdFxjrj7cmKbN4K5v8RGxT2sJMTpwBflNHhUJgBdoUylzy3TuwIDBRi0hf9p9VtbW3qk30X7q2Je1IybZq7mLVWFKTSADXPoqi9AzVorda0kKTS6KkRbSgaR1GT1h5CObYiW1GU27yc5z6F9Fn/yTYedeLi9AIA6AbgxGIxAMPZcZeUHH9cFavVfY97FaNA/DbazRZVV89/61at2BTlg1JXiFtrYoBmRyd7p6/UP0XxaSDmy4pt0jmuh8qx6wQ2MmRz18TaJCUWO9xisUVhMMsoZZDiGHLLuXUbso2iatP/1HvhYu3n3bh6Pe/LUjZSj1NUJ8lSlNwahRRlMRjmyFDICikVn8+SacomdbZTVj+0mQSxweS1WqpiHK/Ncubs858f9idOJ/qKS1cv+RbFuIbMmHEvTbO4QeF25CxyD62nSbmJ1MUzRrpiwR0RPBJMpnCGxWVGXBn8TkarNGQHjuPrxOeWY4GY9FmxWHy19Gvv+ayYF6f8oYi7i8U93bjFkYokvbhWEFu8Og2ZxrUe3NMpc3vLhqqYpVV4XbwDQkpgoVwYKOR9N5d+eXB5vJevQA0pD7oVqi4WOj16vX6EYSA08WKvyeOZJw1cQ6rsnXOa/RYoM0Kls0zLuVoHhHAHL8YFXkwVCoE8uXhvMVCY8mW5Ci8eKkcgJ9azOl0UajNDFiUpj5JeloEqTgwd/iCUJP0sFMSejkpO96b4zl1fPuYiyd6Vs4GBmHSsJoYmLy/WeBTlis5rlJYrgjhe1s+XOXGEtHJOMl4VB2EHLauKdyG7JBLIc//uslRKkhOrcGJqyiU9z5UkOpVOwiGXSyQizRAfqlRc7Y5KJFnV6FReiWSV7xAWeQd/SOSq6qY18eVHq4vjlyazEJ73ScmJPVxJVKdF9MFwYpFIEL+ehvDOcSH8YXRsAa4XfwS7kd0tLfw7Sp7fl7xJywbYjTTVotfTb+849lEcb0K+2lMN/5o+tons+Rxp+PrQ8U3n0BcNSGPj4W+bPuX5ZLNo+uxwY+PfoLJHX1KXgyMAAAAASUVORK5CYII=" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0},"limitreport":{"cputime":"0.125","walltime":"0.455","ppvisitednodes":{"value":558,"limit":1000000},"postexpandincludesize":{"value":4747,"limit":2097152},"templateargumentsize":{"value":1401,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":1853,"limit":5000000},"timingprofile":["100.00%  226.692      1 Template:Article","100.00%  226.692      1 -total"," 66.60%  150.974      4 Template:Infobox_section"," 16.96%   38.452      4 Template:UserLookup","  2.38%    5.395      1 Template:Get_active_contest","  2.02%    4.578      1 Template:Review_expired","  0.96%    2.167      1 Template:Infobox_begin","  0.41%    0.923      1 Template:Infobox_end"]},"cachereport":{"timestamp":"20230306035150","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":1371});});</script></body>
</html>